Viewing Study NCT02665234


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-03-03 @ 4:49 PM
Study NCT ID: NCT02665234
Status: COMPLETED
Last Update Posted: 2019-08-16
First Post: 2016-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
Sponsor: Mimetogen Pharmaceuticals USA, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module